Metyrosine and pheochromocytoma

Archives of Internal Medicine

Volumn 157, Issue 8, 1997, Pages 901-906

  Steinsapir, Jaime ^a,c,d   Carr, Albert A ^b   Prisant, L Michael ^a   Bransome Jr , Edwin D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Circulatory Disease Center   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METIROSINE; PHENOXYBENZAMINE; PRAZOSIN;

ADULT; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE REGULATION; CATECHOLAMINE RELEASE; CLINICAL ARTICLE; DEPRESSION; DRUG EFFECT; FEMALE; GALACTORRHEA; HUMAN; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PSYCHOSIS; SOMNOLENCE; VISUAL HALLUCINATION;

EID: 0031396556     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.8.901     Document Type: Article

References (24)

1. Bravo EL. Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma. Endocr Rev. 1994;5:356-368.
2. Werbel SS, Ober KP. Pheochromocytoma: update in diagnosis, localization and management: endocrine emergencies. Med Clin North Am. 1995;79:131-153.
3. Boutros AR, Bravo EL, Zanettin G, Straffon RA. Perioperative management of 63 patients with pheochromocytoma. Cleve Clin J Med. 1990; 57:613-617.
4. Karet FE, Brown MJ. Pheochromocytoma: diagnosis and management. Post-grad Med J. 1994;70:326-328.
5. Pisano JJ. A simple analysis for noremetanepherine and metanepherine in urine. Clin Chem Acta. 1960;5:406-414.
6. Davis GC, Kissinger PJ, Shoup PE. Strategies for determination of serum or plasma norepinephrine by reverse phase liquid chromatography. Anal Chem. 1981;53:156-159.
7. Chatal J, Charbonnel B. Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. J Clin Endocrinol Metab. 1985;61:769-772.
8. Quint L, Glazer G, Frances F, Shapiro B, Chenevert T. Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology. 1987;165:89-93.
9. Jones NF, Walker G, Ruthven CRJ, Sandier M. Alpha-methyl-p-tyrosine in the management of pheochromocytoma. Lancet. 1968;2:1105-1109.
10. Engelman K, Horowitz D, Jequier E, Sjoerdsma A. Biochemical and pharmacologic effects of alpha methyl-tyrosine in men. J Clin Invest. 1968;47:577-594.
11. Gifford RW, Manger WM, Bravo EL. Pheochromocytoma. Endocrinol Metab Clin North Am. 1994;23:387-404.
12. Turner P. Some clinical implications of the receptor concept. Circ Res. 1980; 46(suppl 1):10-14.
13. Sjoerdsma A, Engelman D, Spector S, Udenfriend S. Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine: an inhibitor of tyrosine hydroxylase. Lancet. 1965;2:1092-1094.
14. Perry RR, Keiser HR, Norton JA, et al. Surgical management of pheochromocytoma with the use of metyrosine. Ann Surg. 1990;212:621-628.
15. Stein P, Black HR. A simplified diagnostic approach to pheochromocytoma: a review of the literature and report of one institution's experience. Medicine. 1990;70:46-66.
16. Feldman JH. Diagnosis and management of pheochromocytoma. Hosp Pract. 1989;175-198.
17. Benowitz NL. Pheochromocytoma. Adv Intern Med. 1990;35:195-220.
18. Desmonts JM, Marty J. An anesthetic management of patients with pheochromocytoma. Br J Anaesth. 1984;56:781-789.
19. Samaan NA, Hickey RC. Pheochromocytoma. Semin Oncol. 1987;14:297-305.
20. Nicholson JP Jr, Vaughn ED Jr, Pickering TG, et al. Pheochromocytoma and prazosin. Ann Intern Med. 1983;99:477-479.
21. Hauptman JB, Modlinger RS, Ertel NH. Pheochromocytoma resistant to alpha-adrenergic blockade. Arch Intern Med. 1983;143:2321-2323.
22. Green KN, Larsson SK, Beevers DG, et al. Alpha-methyl tyrosine in the management of pheochromocytoma. Thorax. 1982;37:632-633.
23. Ram CVS, Meese R, Hill SC. Failure of alpha-methyl tyrosine to prevent hypertensive crisis in pheochromocytoma. Arch Intern Med. 1985;145:2114-2115.
24. Okun R. New medications, 1981. Ann Rev Pharmacol Toxicol. 1981;21:597-604.